IFNG and systemic lupus erythematosus: BM-MSCs can inhibit antigen-dependent proliferation and differentiation into plasma cells of follicular and marginal zone B cells in SLE mice via the IFN-γ and PD-1/PD-L1 pathways, thereby contributing to the prevention of glomerular damage [171].